קוסליוגו 10 מג ישראל - עברית - Ministry of Health

קוסליוגו 10 מג

astrazeneca (israel) ltd - selumetinib as hyd-sulfate - קפסולה קשיחה - selumetinib as hyd-sulfate 10 mg - selumetinib

קוסליוגו 25 מג ישראל - עברית - Ministry of Health

קוסליוגו 25 מג

astrazeneca (israel) ltd - selumetinib as hyd-sulfate - קפסולה קשיחה - selumetinib as hyd-sulfate 25 mg - selumetinib

טזספייר ישראל - עברית - Ministry of Health

טזספייר

astrazeneca (israel) ltd - tezepelumab - תמיסה להזרקה - tezepelumab 110 mg/ml - tezepelumab

וקסיגריפ ישראל - עברית - Ministry of Health

וקסיגריפ

medici medical ltd, israel - a/michigan/45/2015 (h1n1)pdm09-like virus; a/singapore/infimh-16-0019/2016 (h3n2) - like virus; b/colorado/06/2017- like virus (b/victoria/2/87 lineage); b/phuket/3073/2013 - like virus (b/yamagata/16/88 lineage) - תרחיף להזרקה - b/phuket/3073/2013 - like virus (b/yamagata/16/88 lineage) 15 mcg/dose; a/michigan/45/2015 (h1n1)pdm09-like virus 15 mcg/dose; a/singapore/infimh-16-0019/2016 (h3n2) - like virus 15 mcg/dose; b/colorado/06/2017- like virus (b/victoria/2/87 lineage) 15 mcg/dose - influenza, inactivated, whole virus - influenza, inactivated, whole virus - for the prevention of influenza.

אווקסים  160 U ישראל - עברית - Ministry of Health

אווקסים 160 u

medici medical ltd, israel - hepatitis a vaccines - תרחיף להזרקה - hepatitis a vaccines 160 au / 0.5 ml - hepatitis a, inactivated, whole virus - hepatitis a, inactivated, whole virus - for active immunisation against infection caused by hepatitis a virus in adults and adolescents over the age of 15

אווקסים פדיאטרי 80 U ישראל - עברית - Ministry of Health

אווקסים פדיאטרי 80 u

sanofi israel ltd - hepatitis a vaccines - תרחיף להזרקה - hepatitis a vaccines 80 units / 0.5 ml - hepatitis a, inactivated, whole virus - hepatitis a, inactivated, whole virus - avaxim 80 u pediatric is indicated for active immunisation against infection caused by hepatitis a virus in children aged from 12 months to 15 years inclusive, who are at risk either of contaminating or spreading infection or of a life threatening disease if infected.

פלומיסט ישראל - עברית - Ministry of Health

פלומיסט

astra zeneca israel ltd - a/california/7/2009 (h1n1) 7±0.5 log 10 ffu / 0.2 ml; a/victoria/361/2011 (h3n2) 7±0.5 log 10 ffu / 0.2 ml - internasal spray - influenza, inactivated, whole virus - flumist is a vaccine indicated for the active immunization of individuals 2- 49 years of age against influenza disease caused by influenza virus subtypes a and type b contained in the vaccine.

אינפנריקס הקסא ישראל - עברית - Ministry of Health

אינפנריקס הקסא

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); haemophilus b; hepatitis b vaccines; pertactin; pertussis toxoid (pt); poliovirus type 1 inactivated; poliovirus type 2 inactivated; poliovirus type 3 inactivated; tetanus toxoid - אבקה ותרחיף להכנת תרחיף להזרקה - filamentous haemagglutinin (fha) 25 mcg/dose; diphtheria toxoid nlt 30 iu/dose; tetanus toxoid nlt 40 iu/dose; hepatitis b vaccines 10 mcg/dose; poliovirus type 1 inactivated 40 du/dose; poliovirus type 2 inactivated 8 du/dose; poliovirus type 3 inactivated 32 du/dose; haemophilus b 10 mcg/dose; pertactin 8 mcg/dose; pertussis toxoid (pt) 25 mcg/dose - bacterial and viral vaccines, combined - infantix hexa is indicated for primary and booster vaccination of infants against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and disease caused by haemophilus influenza type b.

נזוקורט אקווה 32 מקגמנה ישראל - עברית - Ministry of Health

נזוקורט אקווה 32 מקגמנה

astra zeneca (israel) ltd - budesonide micronized - ספריי לאף - budesonide micronized 0.64 mg/ml - budesonide - budesonide - seasonal and perennial allergic rhinitis, and vasomotor rhinitis. preventively against nasal polyps after polypectomy. symptomatic treatment in nasal polyposis.

נזוקורט אקווה 64 מקגמנה ישראל - עברית - Ministry of Health

נזוקורט אקווה 64 מקגמנה

astra zeneca (israel) ltd - budesonide micronized - ספריי לאף - budesonide micronized 1.28 mg/ml - budesonide - budesonide - seasonal and perennial allergic rhinitis, and vasomotor rhinitis. preventively against nasal polyps after polypectomy. symptomatic treatment in nasal polyposis.